CJC-1295 (NO DAC) + Ipamorelin Blend Peptide Research Applications & Key Findings Growth Hormone Secretion Research Pituitary Function Studies Extensive research has examined the growth hormone secretagogue properties of the CJC-1295 + Ipamorelin combination across multiple species: Dose-dependent GH release demonstrated in rat anterior pituitary cell cultures with picomolar to micromolar peptide concentrations 2- to 10-fold increases in plasma growth hormone levels sustained for 6 days in human subjects following single CJC-1295 dose Preserved pulsatile secretion with ipamorelin addition, preventing continuous non-physiological stimulation Selective action on growth hormone release without affecting prolactin, ACTH, cortisol, FSH, or TSH levels Human trials with healthy subjects aged 21-61 years demonstrated sustained, dose-dependent increases in growth hormone and IGF-1 levels that were safe and well-tolerated at doses of 30-60 mcg/kg
View Tesamorelin / Ipamorelin Blend
And so it has the same effect: it tells your body to produce more growth hormone
That's the standard we hold ourselves to, and it's the standard every serious researcher should demand
As a byproduct, these medications also slow digestion, reduce nutrient intake and can sometimes lead to side effects such as fatigue
Extensive Screening Before Taking Ozempic Is Crucial Because health and family history is so important, Huggins reiterates that careful screening is important before starting medications like Wegovy or Ozempic: People respond to medicines differently, so clear and thorough communication with ones health care professional is very important to make sure a GLP1 medication are safe for the user, she explains
